Dr. Ahmed Abdelbaki, MD

Dr. Abdelbaki practices at Guthrie Robert Packer Hospital in Sayre, Pennsylvania, part of The Guthrie Clinic.

Dr. Abdelbaki's NPI, 1396152005, was assigned on July 14, 2014. Dr. Abdelbaki holds Missouri license 2020013946.

Dr. Abdelbaki's primary practice is Guthrie Robert Packer Hospital, at One Guthrie Square, Sayre, PA 18840 in Bradford County. The practice phone is (570) 888-6666. Dr. Abdelbaki also practices at Guthrie Robert Packer Hospital, 1 Guthrie Sq, Sayre, PA 18840.

Dr. Abdelbaki's primary practice is Guthrie Robert Packer Hospital in Sayre, Pennsylvania, part of The Guthrie Clinic. Dr. Abdelbaki is also affiliated with Guthrie Corning Hospital. The medical group on file is Guthrie Medical Group. Dmand AI also links Dr. Abdelbaki to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdelbaki practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Abdelbaki's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Abdelbaki is licensed in Missouri.

CMS data shows 276 Medicare services from Dr. Abdelbaki across 11 procedure codes in 2024, for 188 Medicare patients. Medicare paid $18,697 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 188 Medicare patients who saw Dr. Abdelbaki in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdelbaki's median patient age at 70, with 51% women.

In 2024, Dr. Abdelbaki wrote 13 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $50 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Abdelbaki for performance year 2024, reported as part of a group. Dr. Abdelbaki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Abdelbaki, published from 2017 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Magnetic Resonance Imaging and Pancreatic Neoplasms. Dr. Abdelbaki has published most often in Proc (Bayl Univ Med Cent). Dr. Abdelbaki's most frequent co-authors are Nishant Gupta, MD, Yogesh Kumar, MD and Somashekar Gopala Krishna, MD.

CMS Open Payments shows 73 general payments to Dr. Abdelbaki from 16 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $455.